Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, completed the expansion of its global manufacturing and distribution facilities in Roswell, Georgia. The expansion, which increases the facility's total size to 18,400 sq. ft., adding 6,000 sq. ft. of adjacent space, enhances warehousing and sales order fulfillment efficiencies while increasing manufacturing capacity five-fold to support the growing demand for Zomedica's products.

"As we continue to strengthen operations at our Roswell facility, the additional warehousing and order fulfillment capacity will drive improved efficiencies," stated Tony Blair, Executive Vice President and Chief Operating Officer. "The Roswell Global Manufacturing and Distribution Center is managed by a quality team with extensive operational experience. We will continue leveraging and enhancing this expertise to increase capacity and streamline global distribution for our current and future product lines."

Zomedica manufactures several key product lines, including TRUVIEW^TM, VetGuardian^®, Assisi^®, and PulseVet^® products, as well as TRUFORMA^® instruments, at the Roswell facility. TRUFORMA^® cartridges are manufactured at the Company's Plymouth, Minnesota facility.

"I'm extremely pleased with the progress at our Roswell facility," stated Larry Heaton, Zomedica's Chief Executive Officer. "This expansion comes right on time as our product lines and associated sales are growing at a rapid pace. Our goal remains the same, to fulfill customer demand for our expanding portfolio of products with efficient production and distribution, as we remain committed to expanding our manufacturing capacity and capabilities.